News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
705,630 Results
Type
Article (40947)
Company Profile (256)
Press Release (664427)
Multimedia
Podcasts (52)
Webinars (12)
Section
Business (205320)
Career Advice (2034)
Deals (35583)
Drug Delivery (96)
Drug Development (81575)
Employer Resources (172)
FDA (16296)
Job Trends (14990)
News (347283)
Policy (32915)
Tag
Academia (2595)
Accelerated approval (5)
Adcomms (21)
Allergies (87)
Alliances (49859)
ALS (95)
Alzheimer's disease (1396)
Antibody-drug conjugate (ADC) (135)
Approvals (16292)
Artificial intelligence (267)
Autoimmune disease (22)
Automation (17)
Bankruptcy (369)
Best Places to Work (11729)
BIOSECURE Act (19)
Biosimilars (107)
Biotechnology (180)
Bladder cancer (80)
Brain cancer (27)
Breast cancer (296)
Cancer (2335)
Cardiovascular disease (181)
Career advice (1703)
Career pathing (30)
CAR-T (158)
Cell therapy (445)
Cervical cancer (20)
Clinical research (66399)
Collaboration (862)
Company closure (2)
Compensation (569)
Complete response letters (20)
COVID-19 (2717)
CRISPR (41)
C-suite (252)
Cystic fibrosis (102)
Data (2340)
Decentralized trials (2)
Denatured (19)
Depression (45)
Diabetes (278)
Diagnostics (6435)
Digital health (19)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (120)
Drug pricing (106)
Drug shortages (25)
Duchenne muscular dystrophy (97)
Earnings (87189)
Editorial (40)
Employer branding (21)
Employer resources (146)
Events (113558)
Executive appointments (751)
FDA (17682)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (781)
Gene editing (109)
Generative AI (20)
Gene therapy (316)
GLP-1 (732)
Government (4538)
Grass and pollen (4)
Guidances (162)
Healthcare (19038)
Huntington's disease (24)
IgA nephropathy (28)
Immunology and inflammation (126)
Indications (29)
Infectious disease (2867)
Inflammatory bowel disease (144)
Inflation Reduction Act (9)
Influenza (55)
Intellectual property (99)
Interviews (319)
IPO (16562)
IRA (40)
Job creations (3669)
Job search strategy (1442)
Kidney cancer (10)
Labor market (43)
Layoffs (477)
Leadership (18)
Legal (7971)
Liver cancer (76)
Lung cancer (329)
Lymphoma (157)
Machine learning (9)
Management (58)
Manufacturing (331)
MASH (78)
Medical device (13469)
Medtech (13474)
Mergers & acquisitions (19592)
Metabolic disorders (717)
Multiple sclerosis (83)
NASH (16)
Neurodegenerative disease (95)
Neuropsychiatric disorders (27)
Neuroscience (1960)
NextGen: Class of 2025 (6572)
Non-profit (4555)
Now hiring (40)
Obesity (375)
Opinion (215)
Ovarian cancer (81)
Pain (91)
Pancreatic cancer (89)
Parkinson's disease (154)
Partnered (22)
Patents (246)
Patient recruitment (116)
Peanut (47)
People (57805)
Pharmaceutical (64)
Pharmacy benefit managers (20)
Phase I (20699)
Phase II (29225)
Phase III (21801)
Pipeline (1390)
Policy (147)
Postmarket research (2576)
Preclinical (8823)
Press Release (65)
Prostate cancer (109)
Psychedelics (30)
Radiopharmaceuticals (250)
Rare diseases (385)
Real estate (5955)
Recruiting (65)
Regulatory (22553)
Reports (48)
Research institute (2349)
Resumes & cover letters (352)
Rett syndrome (6)
RNA editing (5)
RSV (43)
Schizophrenia (75)
Series A (133)
Series B (91)
Service/supplier (13)
Sickle cell disease (52)
Special edition (16)
Spinal muscular atrophy (149)
Sponsored (31)
Startups (3625)
State (2)
Stomach cancer (13)
Supply chain (68)
Tariffs (51)
The Weekly (31)
Vaccines (735)
Venture capitalists (44)
Weight loss (242)
Women's health (36)
Worklife (16)
Date
Today (129)
Last 7 days (976)
Last 30 days (3240)
Last 365 days (32635)
2025 (12019)
2024 (35404)
2023 (40255)
2022 (51404)
2021 (56008)
2020 (54591)
2019 (46915)
2018 (35359)
2017 (32315)
2016 (31768)
2015 (37803)
2014 (31593)
2013 (26642)
2012 (28859)
2011 (29529)
2010 (27636)
Location
Africa (748)
Alabama (54)
Alaska (7)
Arizona (233)
Arkansas (13)
Asia (38498)
Australia (6273)
California (6445)
Canada (2072)
China (543)
Colorado (275)
Connecticut (281)
Delaware (158)
Europe (82505)
Florida (959)
Georgia (216)
Idaho (57)
Illinois (550)
India (25)
Indiana (323)
Iowa (11)
Japan (173)
Kansas (106)
Kentucky (24)
Louisiana (11)
Maine (62)
Maryland (937)
Massachusetts (4799)
Michigan (226)
Minnesota (407)
Mississippi (2)
Missouri (82)
Montana (27)
Nebraska (26)
Nevada (68)
New Hampshire (63)
New Jersey (1802)
New Mexico (28)
New York (1814)
North Carolina (1009)
North Dakota (8)
Northern California (2845)
Ohio (211)
Oklahoma (14)
Oregon (34)
Pennsylvania (1432)
Puerto Rico (13)
Rhode Island (33)
South America (1118)
South Carolina (26)
South Dakota (1)
Southern California (2418)
Tennessee (106)
Texas (958)
United States (24177)
Utah (190)
Virginia (155)
Washington D.C. (64)
Washington State (569)
West Virginia (3)
Wisconsin (57)
705,630 Results for "emergent biosolutions inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Emergent BioSolutions Reports First Quarter 2025 Financial Results
May 8, 2025
·
31 min read
Press Releases
Emergent BioSolutions Announces Stock Repurchase Program
April 1, 2025
·
3 min read
Press Releases
Emergent BioSolutions to Report First Quarter 2025 Financial Results on May 7, 2025
April 23, 2025
·
1 min read
Press Releases
Artis BioSolutions Emerges from Stealth, Announces Acquisition of Landmark Bio
April 2, 2025
·
5 min read
Press Releases
Emergent BioSolutions Announces Approximately $27 Million in Incremental Sales to Supply International Customers with Five Critical Medical Countermeasure Products
March 19, 2025
·
1 min read
Press Releases
Emergent BioSolutions Announces Sale of Baltimore-Bayview Manufacturing Site to Syngene International
March 10, 2025
·
4 min read
Press Releases
Emergent BioSolutions New Hire Equity Grant Under NYSE Rule 303A.08
March 21, 2025
·
1 min read
Press Releases
Emergent BioSolutions Reports Fourth Quarter and Full Year 2024 Financial Results
March 4, 2025
·
41 min read
Press Releases
Emergent BioSolutions and Rocketvax Announce Investment Agreement and Pursuit of a Strategic Relationship for Next-Generation Product Candidates
March 12, 2025
·
5 min read
BioCapital
Emergent BioSolutions Announces Amendment to its Existing Credit Facility
Emergent BioSolutions Inc. announced that it has entered into a “Consent, Waiver and Seventh Amendment” to its existing credit facility.
April 30, 2024
·
2 min read
1 of 70,563
Next
